Quick Answer
NP Life Sciences Health Industry Group Inc. reported Stockholders Equity of $19.3 thousand for the year ending 2022.
- NP Life Sciences Health Industry Group Inc. showed a decrease of -49.4% in Stockholders Equity from 2021 to 2022.
- This data is from NP Life Sciences Health Industry Group Inc.'s annual report (Form 10-K), filed with the SEC on April 18, 2023.
- XBRL data for this metric is available from 2018 to 2022 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2019: $277.2 thousand | Q1 2020: $204.8 thousand | Q2 2020: $151.1 thousand | Q3 2020: $125.5 thousand | Q1 2021: $79.6 thousand | Q2 2021: $26.9 thousand | Q3 2021: $5.9 thousand | Q4 2021: $38.2 thousand | Q1 2022: $7.1 thousand | Q2 2022: $8.2 thousand | Q3 2022: $2.7 thousand | Q4 2022: $19.3 thousand | Q1 2023: $20.5 thousand | Q2 2023: $67.1 thousand | Q3 2023: $31.7 thousand.
- Over the full 5 years of available data (2018 to 2022), NP Life Sciences Health Industry Group Inc.'s Stockholders Equity has grown by 193.4%.
- Historical annual values: Fiscal year 2022: $19.3 thousand | Fiscal year 2021: $38.2 thousand | Fiscal year 2020: $103.8 thousand | Fiscal year 2019: $234.9 thousand | Fiscal year 2018: -$20.7 thousand.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: